Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. Therefore, we selected relevant effect indicators, oxidative damage indicators and genotoxicity indicators to research the damage of the tar content to the body. Cotinine can be used to evaluate the nicotine exposure level in the human body for 3–4 days.

  2. Tar, when in the lungs, coats the cilia causing them to stop working and eventually die, causing conditions such as lung cancer as the toxic particles in tobacco smoke are no longer trapped by the cilia but enter the alveoli directly.

  3. 16 sty 2024 · ER stress inhibition alleviates tar-induced atherosclerosis progression. For the ER stress inhibition experiment, 8-week-old male ApoE −/− mice were treated with or without 4PBA (100 mg/kg every other day) by intraperitoneal injection immediately after tar-infusion and for the following 16 weeks.

  4. 28 lut 2018 · Seventeen studies reported results for lung cancer, 16 for heart disease, five for stroke and four for COPD. Three studies used surrogate measures for tar; nicotine in two studies of heart disease, and a combined tar and nicotine index in a study of all four diseases.

  5. 20 maj 2020 · Objective: To explore the genetic damage caused by different tar levels in the human body. Methods: The subjects were divided into high, medium and low (12 mg, 8 mg, 5 mg) tar groups according to the tar levels.

  6. Smokers have a much higher rate of coronary artery disease, CAD, than do non-smokers. Part of this increased risk is attributable to the nicotine in cigarettes, but tar also plays a significant role. Some of the compounds in tar are adsorbed through the lungs and enter the bloodstream.

  7. www.nhsinform.scot › healthy-living › stopping-smokingTobacco - NHS inform

    15 sie 2024 · Tar damages your lungs by narrowing the small tubes (bronchioles) that absorb oxygen. It also damages the small hairs (cilia) that help protect your lungs from dirt and infection. This lead to a range of lung diseases like chronic obstructive pulmonary disease (COPD) and emphysema.